Epidemiological studies on benefits and harms of drug treatment – special focus on drug safety in pregnancy and childhood.
Project
|Updated
The purpose of the study is to link data from health registries and some other data sources in five Nordic countries to investigate drug use in women of childbearing age, expectant fathers and children. Outcomes will be short-term and long-term effects in children after being exposed in utero or later in life, as well as consequences for the mother whether she continues or stops treatment while she is pregnant.
Project leader
Kari Furu, Norwegian Institute of Public Health
Project participants
Inger Johanne Landsjøåsen Bakken, Centre for Fertility and Health, Norwegian Institute of Public Health
Siri Eldevik Håberg, Centre for Fertility and Health, Norwegian Institute of Public Health
Lars Jøran Kjerpeseth, Department of Chronic Diseases, Norwegian Institute of Public Health
Vidar Hjellvik, Department of Chronic Diseases, Norwegian Institute of Public Health
Jacqueline Mallory Cohen, Department of Chronic Diseases, Norwegian Institute of Public Health
Randi Marie Selmer, Physical Health and Ageing, Norwegian Institute of Public Health
Maria Christine Magnus, Centre for Fertility and Health, Norwegian Institute of Public Health
Viktor Wintzell, Karolinska Institutet
Bjørn Pasternak, Karolinska Institutet
Helga Zoega, University of Iceland
Mette Nørgaard, Aarhus University
Helle Kieler, Karolinska Institutet
Mika Gissler, National Institute for Health and Welfare
Pär Karlsson, Karolinska Institutet
Carolyn Cesta, Karolinska Institutet
Eva Skovlund, Norwegian University of Science and Technology
Kari Klungsøyr, Norwegian Institute of Public Health
Øystein Karlstad, Norwegian Institute of Public Health
Anders Engeland, Norwegian Institute of Public Health
Start
01.01.2018
End
01.02.2032
Status
Active
Approvals
Regional committees for medical and health research ethics
Project owner/ Project manager
Norwegian Institute of Public Health